Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer-Reference-Cited by-同舟云学术

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

Published:2016-08 Issue: Volume:164 Page:152-169
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Wigerup Caroline,Påhlman Sven,Bexell Daniel

Funder

Berta Kamprad Foundation

Swedish Cancer Society

Swedish Childhood Cancer Foundation

Swedish Research Council, VINNOVA

SSF Strategic Center for Translational Cancer Research-CREATE Health

Strategic Cancer Research Program BioCARE

Crafoord Foundation

The Royal Physiographic Society in Lund

Gunnar Nilsson's Cancer Foundation

Hans von Kantzows' Foundation

Jeanssons Stiftelser

The Krapperup Foundation

Region Skåne and Skåne University Hospital research funds

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference289 articles.

1. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer;Aebersold;Cancer Res,2001

2. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas;Amar;J Clin Endocrinol Metab,2007

3. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression;Amelio;Trends Biochem Sci,2015

4. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha;An;Nature,1998

5. Immunity, inflammation and cancer: a leading role for adenosine;Antonioli;Nat Rev Cancer,2013

Cited by 530 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A quartet of cancer stem cell niches in hepatocellular carcinoma;Cytokine & Growth Factor Reviews;2024-10

2. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications;Molecular Cancer;2024-09-07

3. Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells;Nature Communications;2024-09-06

4. Tailoring polymeric nanocarriers for hypoxia-specific drug release: Insights into design and applications in clinics;Chemical Engineering Journal;2024-09

5. HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications;Life Sciences;2024-09